Complementtech

Supplies complement reagents to biomedical research community worldwide.

About Complementtech

It operates as a B2B. The company has 6 employees. Complementtech offers products and services including Purified Proteins, Animal Proteins, Polyclonal Antisera, Depleted Sera, and Complement Assay Reagents.

  • Employees 6
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website complementtech.com
  • Legal Name Complement Technology, Inc.
Key Metrics
  • Employee Count
    6

Products & Services of Complementtech

Complementtech offers a comprehensive portfolio of products and services, including Purified Proteins, Animal Proteins, Polyclonal Antisera, Depleted Sera, and Complement Assay Reagents.

Purified Proteins
Reagents

High-quality proteins for biomedical research applications

Animal Proteins
Reagents

Proteins from animals used in scientific studies

Polyclonal Antisera
Antibodies

Antisera for complement-related research purposes

Depleted Sera
Sera Products

Sera depleted for specific immune component studies

Complement Assay Reagents
Assay Tools

Reagents for testing complement system functions

Web traffic of Complementtech

Websites that share an audience with Complementtech (complementtech.com).

Similar websites

Websites whose visitors overlap most with Complementtech. Affinity shows how closely the audiences match.

Similar companies to Complementtech

10 companies that operate in the same segment as Complementtech (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
2008Ghent, East Flanders, BelgiumUSD 61.9 MUSD 1.41 B355
Targeted and immune-oncology drugs for cancer treatment are developed.
2010Cambridge, Massachusetts, United StatesUSD 172 M––
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Targeted therapies for cancer treatment are developed.
2005Waltham, Massachusetts, United StatesUSD 198.29 MUSD 172.35 M270
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Plasma-based biologics are developed for immune deficiency and infectious diseases.
2005Ramsey, Minnesota, United StatesUSD 17.55 MUSD 510.17 M685
Antibody drugs for cancer treatment are developed.
2015Singapore, SingaporeUSD 150 M––
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
2013Seattle, Washington, United StatesUSD 316.67 M–520
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
2003United StatesUSD 171.85 MUSD 102.48 M338
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Complementtech

Complementtech has 6 employees.

Complement Technology, Inc. manufactures and distributes high-quality complement reagents, including purified proteins and polyclonal antisera, for the biomedical research sector. Based in Tyler, Texas, USA, they serve global scientists by providing original products with over 80 years of combined expertise. They accept orders via phone, fax, or online, focusing on advancing medical research needs.

Complementtech offers Purified Proteins, Animal Proteins, Polyclonal Antisera, Depleted Sera, and Complement Assay Reagents.

Complementtech operates through Complement Technology, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available